These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 25866816)

  • 21. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
    Jacob R; Welkoborsky HJ; Mann W
    Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acquired pediatric cholesteatoma: predictive factors of recurrence. A retrospective study of 11 years].
    Farah C; Rouhayem Z; Nassif C; Rassi S
    J Med Liban; 2014; 62(1):7-13. PubMed ID: 24684120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesteatoma in children.
    Hildmann H; Sudhoff H
    Int J Pediatr Otorhinolaryngol; 1999 Oct; 49 Suppl 1():S81-6. PubMed ID: 10577781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of diffusion-weighted MR imaging in the detection of middle ear cholesteatoma].
    Nagai N; Tono T; Matsuda K; Toyama K; Kawano H; Kodama T
    Nihon Jibiinkoka Gakkai Kaiho; 2007 Nov; 110(11):707-12. PubMed ID: 18064874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution microendoscope images of middle ear cholesteatoma and surrounding tissue: evaluation of interobserver concordance.
    Bradley J; Jiang N; Levy L; Richards-Kortum R; Sikora A; Smouha E
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):654-8. PubMed ID: 24415492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research.
    Kuo CL
    Laryngoscope; 2015 Jan; 125(1):234-40. PubMed ID: 25123251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of scutum erosion in the diagnosis of temporal bone cholesteatoma.
    Yu Z; Han D; Gong S; Wang Z; Zhang L
    Acta Otolaryngol; 2010; 130(1):47-51. PubMed ID: 19579143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family cluster of cholesteatoma.
    Homøe P; Rosborg J
    J Laryngol Otol; 2007 Jan; 121(1):65-7. PubMed ID: 17059626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesteatoma Pearls: Practical Points and Update.
    Castle JT
    Head Neck Pathol; 2018 Sep; 12(3):419-429. PubMed ID: 30069838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging of cholesteatoma: an update.
    Vercruysse JP; De Foer B; Somers Th; Casselman J; Offeciers E
    B-ENT; 2009; 5(4):233-40. PubMed ID: 20163049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of p63 and survivin in cholesteatomas.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune cell profile in invasive cholesteatomas: preliminary findings.
    Hussein MR; Sayed RH; Abu-Dief EE
    Exp Mol Pathol; 2010 Apr; 88(2):316-23. PubMed ID: 20045407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.
    Akimoto R; Pawankar R; Yagi T; Baba S
    ORL J Otorhinolaryngol Relat Spec; 2000; 62(5):257-65. PubMed ID: 10965261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Confirmation of mucin in lymphatic vessels of acquired cholesteatoma.
    Nagai T; Suganuma T; Ide S; Shimoda H; Kato S
    Eur Arch Otorhinolaryngol; 2006 Apr; 263(4):361-4. PubMed ID: 16328407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
    Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired cholesteatoma epithelial hyperproliferation: Roles of cell proliferation signal pathways.
    Xie S; Xiang Y; Wang X; Ren H; Yin T; Ren J; Liu W
    Laryngoscope; 2016 Aug; 126(8):1923-30. PubMed ID: 26989841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of potential medical treatments for middle ear cholesteatoma.
    Schürmann M; Goon P; Sudhoff H
    Cell Commun Signal; 2022 Sep; 20(1):148. PubMed ID: 36123729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of clinical and surgical findings to histological features (koilocytosis, papillary hyperplasia) suggesting papillomavirus involvement in the pathogenesis of cholesteatoma.
    Ferekidis E; Nikolopoulos TP; Yiotakis J; Ferekidou E; Kandiloros D; Papadimitriou K; Tzangaroulakis A
    Med Sci Monit; 2006 Sep; 12(9):CR368-71. PubMed ID: 16940929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological considerations about middle ear cholesteatoma.
    Măru N; Pop F
    Rom J Morphol Embryol; 2006; 47(1):73-7. PubMed ID: 16838062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.